- Home
- MTNB vs GNLN Comparison
MTNB vs GNLN Comparison
Compare MTNB & GNLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTNB | GNLN |
|---|---|---|
| Founded | 2013 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Durable Goods |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6M | 2.1M |
| IPO Year | 2014 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MTNB | GNLN |
|---|---|---|
| Price | $2.74 | $2.68 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 341.7K | 24.3K |
| Earning Date | 08-13-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.84 | 21.57 |
| EPS | ★ N/A | N/A |
| Revenue | $119,750.00 | ★ $13,275,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.15 | $1.51 |
| 52 Week High | $3.16 | $181.20 |
Technical Indicators
Market Signals| Indicator | MTNB | GNLN |
|---|---|---|
| Relative Strength Index (RSI) | 74.24 | 48.61 |
| Support Level | $0.39 | $2.71 |
| Resistance Level | N/A | $2.75 |
| Average True Range (ATR) | 0.28 | 0.30 |
| MACD | 0.10 | -0.02 |
| Stochastic Oscillator | 87.33 | 21.93 |
Price Performance
Historical ComparisonAbout MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.
About GNLN Greenlane Holdings Inc.
Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). It serves specialty retailers, smoke shops, head shops, convenience stores, and consumers. Geographically, it operates in United States, Canada, and Europe. It derives majority revenue from the United States. Its two operating segments are: Wholesale and Distribution, which includes legacy e-commerce and drop-ship operations; and Digital Assets, which includes digital asset treasury activities including acquisition, staking and validator participation related to BERA.